Evidence map›Paper›PMID 41186820›Full record

ArticleBulletin of experimental biology and medicine2025

Morphological Characteristics of the Lysobacter sp. Hz25 Strain, a Potential Source of Antimicrobial Compounds.

Yu V Nurminskaya, I A Vasiliev, M S Karepova, N B Ayusheeva, Yu A Markova

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu V NurminskayaSiberian Institute of Plant Physiology and Biochemistry, Siberian Branch of the Russian Academy of Sciences, Irkutsk, Russia.
I A VasilievSiberian Institute of Plant Physiology and Biochemistry, Siberian Branch of the Russian Academy of Sciences, Irkutsk, Russia.
M S KarepovaSiberian Institute of Plant Physiology and Biochemistry, Siberian Branch of the Russian Academy of Sciences, Irkutsk, Russia.
N B AyusheevaIrkutsk State University, Irkutsk, Russia.
Yu A MarkovaSiberian Institute of Plant Physiology and Biochemistry, Siberian Branch of the Russian Academy of Sciences, Irkutsk, Russia. juliam06@mail.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the species belonging to the genus Lysobacter, known as micropredators, there are valuable strains-producers of antibiotics that can be effective in the fight against pathogenic microorganisms. The morphological features (pigments and cell sizes) of a new strain Lysobacter sp. Hz25 were studied during cultivation on different media. It was found that the size of Lysobacter sp. Hz25 cells depends on the number of CFU per unit area of solid medium and the location relative to the center of the colony. At low CFU number and at the periphery of the colony, the cells are longer, which indicates their possible transition to a mobile state. The color of the colonies depended on the medium composition. The presence of a complex of yellow hydrophobic pigments in the cells and a complex of hydrophilic pigments secreted into the medium and coloring it pink and yellow was found. Understanding of the effect of the medium composition on the morphology of Lysobacter sp. Hz25 cells and colonies and, consequently, on its interaction with pathogenic microorganisms will allow more complete use of its properties for combating human infections.

Indexed as

Anti-Bacterial AgentsLysobacterPigments, BiologicalCulture MediaHumansAnti-Bacterial AgentsCulture MediaPigments, BiologicalHedysarum zundukiiLysobactermorphologypigmentsrhizosphere

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.